Marble Harbor Investment Counsel LLC lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 5.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 639,938 shares of the pharmacy operator's stock after buying an additional 31,066 shares during the quarter. Marble Harbor Investment Counsel LLC owned about 0.07% of Walgreens Boots Alliance worth $7,148,000 as of its most recent filing with the SEC.
Other large investors have also made changes to their positions in the company. First Trust Advisors LP bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at about $368,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Walgreens Boots Alliance by 6.0% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 87,428 shares of the pharmacy operator's stock worth $978,000 after buying an additional 4,926 shares during the last quarter. Concurrent Investment Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 28.2% during the first quarter. Concurrent Investment Advisors LLC now owns 13,924 shares of the pharmacy operator's stock worth $156,000 after buying an additional 3,064 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Walgreens Boots Alliance during the first quarter worth approximately $1,199,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Walgreens Boots Alliance by 3.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 42,332 shares of the pharmacy operator's stock worth $472,000 after buying an additional 1,341 shares during the last quarter. Institutional investors own 58.59% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the company. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Morgan Stanley restated an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, Wall Street Zen started coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating for the company. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $10.59.
Read Our Latest Stock Report on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Performance
WBA traded up $0.03 during trading on Tuesday, hitting $11.69. The stock had a trading volume of 1,903,528 shares, compared to its average volume of 15,988,508. The company has a 50 day moving average price of $11.44 and a 200-day moving average price of $11.09. The firm has a market cap of $10.11 billion, a price-to-earnings ratio of -1.60, a P/E/G ratio of 1.37 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $13.25.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. The company had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. During the same quarter in the prior year, the company earned $0.63 EPS. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.